PharmIdeas (Canada)

Recent papers from PharmIdeas (Canada)

1. Cost-effectiveness of partially-hydrolyzed formula for prevention of atopic dermatitis in AustraliaJournal of Medical Economics · 2012
2. Economic evaluation of a 100% whey-based partially hydrolyzed infant formula in the prevention of atopic dermatitis among Swiss childrenJournal of Medical Economics · 2011
3. Economic evaluation of a 100% whey-based partially hydrolyzed infant formula in the prevention of atopic dermatitis among Danish childrenJournal of Medical Economics · 2011
4. Elicitation of utility scores in Canada for immune thrombocytopenia treated with romiplostim or watch and rescueJournal of Medical Economics · 2011
5. Partially Hydrolysed 100% Whey-Based Infant Formula and the Prevention of Atopic Dermatitis: Comparative Pharmacoeconomic AnalysesAnnals of Nutrition and Metabolism · 2011
6. Economic evaluation of a 100% whey-based, partially hydrolysed formula in the prevention of atopic dermatitis among French childrenCurrent Medical Research and Opinion · 2010
7. Meta-analysis of a partially hydrolysed 100%-whey infant formula vs. extensively hydrolysed infant formulas in the prevention of atopic dermatitisCurrent Medical Research and Opinion · 2010
8. Association Between Use of Proton Pump Inhibitors and a Clostridium difficile– Associated Disease Outbreak: Case–Control StudyThe Canadian Journal of Hospital Pharmacy · 2010
9. Effect of selected antihypertensives, antidiabetics, statins and diuretics on adjunctive medical treatment of glaucoma: A population based studyCurrent Medical Research and Opinion · 2009
10. Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related painCurrent Medical Research and Opinion · 2006
11. Remission, dropouts, and adverse drug reaction rates in major depressive disorder: a meta-analysis of head-to-head trialsCurrent Medical Research and Opinion · 2006
12. Cost-minimization analysis of treprostinil vs. epoprostenol as an alternate to oral therapy non-responders for the treatment of pulmonary arterial hypertensionCurrent Medical Research and Opinion · 2005
13. Economic evaluation of Avonex® (interferon beta-1a) in patients following a single demyelinating eventMultiple Sclerosis Journal · 2005
14. Cost‐Effectiveness of Treprostinil Versus Epoprostenol in Patients with Pulmonary Arterial Hypertension: A Canadian AnalysisCanadian Respiratory Journal · 2005
15. Association between mean intraocular pressure, disease stability and cost of treating glaucoma in CanadaCurrent Medical Research and Opinion · 2004
16. Cost of Glaucoma in Canada: Analyses Based on Visual Field and Physician's AssessmentJournal of Glaucoma · 2003
17. Cost-utility of risperidone compared with standard conventional antipsychotics in chronic schizophreniaJournal of Medical Economics · 2001